ASTELLAS PHARMA, INC. (ALPMF)
Clinical trial NCT07425574: enrollment: not set → 90 participants.
GSK PLC (GSK)
Clinical trial NCT07121192 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-05-15 → 2026-05-11 3. primary completion date: 2026-05-15 → 2026-05-11 4. enrollment: not set → 776 participants
MERCK & CO., INC. (MRK)
Clinical trial NCT05815927: enrollment: not set → 200 participants.
GILEAD SCIENCES, INC. (GILD)
Clinical trial NCT06477419: enrollment: not set → 33 participants.
ASTRAZENECA PLC (AZN)
Clinical trial NCT05437250: enrollment: not set → 350 participants.
NOVO NORDISK A S (NVO)
Clinical trial NCT06269107: enrollment: not set → 485 participants.
BRISTOL MYERS SQUIBB CO (BMY)
Clinical trial NCT06988488: enrollment: not set → 62 participants.
LYELL IMMUNOPHARMA, INC. (LYEL)
Clinical trial NCT05826535: enrollment: not set → 270 participants.
MERCK & CO., INC. (MRK)
Clinical trial NCT07058077: enrollment: not set → 153 participants.
ARGENX SE (ARGX)
Clinical trial NCT06078553: enrollment: not set → 100 participants.